Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Amir Hossein Miri, Mojtaba Kamankesh, Mazda Rad-Malekshahi, Abbas Yadegar, Maryam Banar, Michael R. Hamblin, Ismaeil Haririan, Hamid Asadzadeh Aghdaei & Mohammad Reza Zali. (2023) Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal against Helicobacter pylori. Expert Review of Anti-infective Therapy 21:6, pages 617-639.
Read now
Read now
Alfizah Hanafiah, Hasyanee Binmaeil, Raja Affendi Raja Ali, Isa Mohamed Rose & Bruno S Lopes. (2019) Molecular characterization and prevalence of antibiotic resistance in Helicobacter pylori isolates in Kuala Lumpur, Malaysia. Infection and Drug Resistance 12, pages 3051-3061.
Read now
Read now
Samantha Flores-Treviño, Soraya Mendoza-Olazarán, Paola Bocanegra-Ibarias, Héctor Jesús Maldonado-Garza & Elvira Garza-González. (2018) Helicobacter pylori drug resistance: therapy changes and challenges. Expert Review of Gastroenterology & Hepatology 12:8, pages 819-827.
Read now
Read now
Giulia Fiorini, Angelo Zullo, Ilaria Maria Saracino, Matteo Pavoni & Dino Vaira. (2018) Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010–2016. Scandinavian Journal of Gastroenterology 53:6, pages 661-664.
Read now
Read now
Articles from other publishers (26)
Yanmeng Wang, Yiling Li, Yuehua Gong, Yuzhen Dong, Jing Sun & Moye Chen. (2023)
Antibiotic resistance characteristics and risk factors analysis of
Helicobacter pylori
strains isolated from patients in Liaoning Province, an area in North China
. PeerJ 11, pages e15268.
Crossref
Crossref
Zhao Chen. (2023)
Mechanisms and Clinical Relevance of
Pseudomonas aeruginosa
Heteroresistance
. Surgical Infections 24:1, pages 27-38.
Crossref
Crossref
Enrico Celestino Nista, Antonio Pellegrino, Lucia Giuli, Marcello Candelli, Tommaso Schepis, Sara Sofia De Lucia, Veronica Ojetti, Francesco Franceschi & Antonio Gasbarrini. (2022) Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature. Antibiotics 11:10, pages 1452.
Crossref
Crossref
Elisabetta Goni, Ina Tammer, Kerstin Schütte, Cosima Thon, Dörthe Jechorek, Ujjwal Mukund Mahajan, Riccardo Vasapolli, Lukas Macke, Benedikt Aulinger, Michael Selgrad, Alexander Link, Peter Malfertheiner & Christian Schulz. (2022) The influence of gastric atrophy on Helicobacter pylori antibiotics resistance in therapy-naïve patients. Frontiers in Microbiology 13.
Crossref
Crossref
Masoud Keikha & Mohsen Karbalaei. (2022) Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis. Microbial Pathogenesis 170, pages 105720.
Crossref
Crossref
Giampaolo Pitruzzello, Christoph G. Baumann, Steven Johnson & Thomas F. Krauss. (2022)
Single‐Cell Motility Rapidly Quantifying Heteroresistance in Populations of
Escherichia coli
and
Salmonella typhimurium
. Small Science 2:5, pages 2100123.
Crossref
Crossref
Salika M. Shakir, Joshua Otiso, George Keller, Hillary Van Heule, Lucas J. Osborn, Nicolynn Cole, Audrey N. Schuetz, Sandra S. Richter & Marc Roger Couturier. (2022) Multicenter Evaluation of a Gradient Diffusion Method for Antimicrobial Susceptibility Testing of Helicobacter pylori. Microbiology Spectrum 10:2.
Crossref
Crossref
Sadaf Ejaz, Saima Ejaz, Ramla Shahid, Tayyaba Noor, Saima Shabbir & Muhammad Imran. (2022) Chitosan-curcumin complexation to develop functionalized nanosystems with enhanced antimicrobial activity against hetero-resistant gastric pathogen. International Journal of Biological Macromolecules 204, pages 540-554.
Crossref
Crossref
Yan Zhao, Yang Li, Zhixian Luan, Cuiping Ma, Lin Yang, Wang Zhang & Chao Shi. (2022) Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detection. Journal of Microbiological Methods 192, pages 106393.
Crossref
Crossref
Ashwini Manjunath, Surya Chandra Rao Thumu, Sumana Kumar & Prakash Motiram Halami. (2021) Bacterial heteroresistance: an evolving novel way to combat antibiotics. Biologia 76:10, pages 3029-3041.
Crossref
Crossref
Zhiyuan Wang, Qiuwen Chen, Jianyun Zhang, Hanlu Yan, Yuchen Chen, Cheng Chen & Xiaoxue Chen. (2021) High prevalence of unstable antibiotic heteroresistance in cyanobacteria causes resistance underestimation. Water Research 202, pages 117430.
Crossref
Crossref
Christos Liatsos, Apostolis Papaefthymiou, Nikolaos Kyriakos, Marios Giakoumis, Jannis Kountouras, Michail Galanopoulos, Periklis Apostolopoulos, Sotirios D. Georgopoulos, Christos Mavrogiannis, Aristomenis K. Exadaktylos, David Shiva Srivastava, Theodore Rokkas & Michael Doulberis. (2020) Evaluation of the Direct Economic Cost per Eradication Treatment Regimen against Helicobacter pylori Infection in Greece: Do National Health Policy-Makers Need to Care?. Medicina 56:3, pages 133.
Crossref
Crossref
Apostolis Papaefthymiou, Christos Liatsos, Sotirios D Georgopoulos, Pericles Apostolopoulos, Michael Doulberis, Nikolaos Kyriakos, Marios Giakoumis, Michael Papadomichelakis, Michail Galanopoulos, Panagiotis Katsinelos, Theodore Rokkas & Jannis Kountouras. (2019)
Helicobacter
pylori
eradication regimens in an antibiotic high‐resistance European area: A cost‐effectiveness analysis
. Helicobacter 25:1.
Crossref
Crossref
Javier P. Gisbert. (2020)
Empirical or susceptibility-guided treatment for
Helicobacter pylori
infection? A comprehensive review
. Therapeutic Advances in Gastroenterology 13, pages 175628482096873.
Crossref
Crossref
Azizollah Yousefi, Shahryar Eslami, Samileh Noorbakhsh, Morteza Haghighi, Leila TaheriNia, Fahimeh Ehsanipour & Sarvenaz Ashouri. (2019) The Resistance Rate of Helicobacter Pylori to Clarithromycin and Main Mutations on Bacterial Genomic Responsible for Bacterial Resistance: A Comparative Study in Children and Adults, Tehran and Iran. Infectious Disorders - Drug Targets 19:4, pages 394-397.
Crossref
Crossref
Yuxia Xiong, Zhibang Yang, Jin Zhang, Jinyang Li, Pu Chen & Yu Xiang. (2019) Panning using a phage-displayed random peptide library to identify peptides that antagonize the Helicobacter pylori ArsS acid-sensing domain. Microbial Pathogenesis 135, pages 103614.
Crossref
Crossref
Tolbert B. Sonda, Pius G. Horumpende, Happiness H. Kumburu, Marco van Zwetselaar, Stephen E. Mshana, Michael Alifrangis, Ole Lund, Frank M. Aarestrup, Jaffu O. Chilongola, Blandina T. Mmbaga & Gibson S. Kibiki. (2019) Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme. PLOS ONE 14:8, pages e0220261.
Crossref
Crossref
Dan I. Andersson, Hervé Nicoloff & Karin Hjort. (2019) Mechanisms and clinical relevance of bacterial heteroresistance. Nature Reviews Microbiology 17:8, pages 479-496.
Crossref
Crossref
Doron Boltin, Olga Ashorov, Lucie Benejat, Dalal Hamouda, Rachel Gingold Belfer, Yaron Niv, Ram Dickman & Tsachi Tsadok Perets. (2019)
Novel high resolution melt curve assay for the analysis of predominance of
Helicobacter pylori
clarithromycin resistance
. Pathogens and Disease 77:4.
Crossref
Crossref
Constantin Hays, Thibault Delerue, Dominique Lamarque, Christophe Burucoa, Ghislaine Collobert, Annick Billöet, Nicolas Kalach & Josette Raymond. (2018)
Molecular diagnosis of
Helicobacter pylori
infection in gastric biopsies: Evaluation of the Amplidiag
®
H. pylori
+ ClariR assay
. Helicobacter 24:2, pages e12560.
Crossref
Crossref
Emily Mosites, Dana Bruden, Julie Morris, Alisa Reasonover, Karen Rudolph, Debra Hurlburt, Thomas Hennessy, Brian McMahon & Michael Bruce. (2018) Antimicrobial resistance among Helicobacter pylori isolates in Alaska, 2000–2016. Journal of Global Antimicrobial Resistance 15, pages 148-153.
Crossref
Crossref
Vern L. Schramm. (2018) Enzymatic Transition States and Drug Design. Chemical Reviews 118:22, pages 11194-11258.
Crossref
Crossref
Tadayuki Oshima & Hiroto Miwa. (2018) Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases. Journal of Neurogastroenterology and Motility 24:3, pages 334-344.
Crossref
Crossref
György M. Buzás. (2018) Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018. Minerva Gastroenterologica e Dietologica 64:3.
Crossref
Crossref
Min Luo, Yi-Yang Jia, Zi-Wei Jing, Chen Li, Si-Yuan Zhou, Qi-Bing Mei & Bang-Le Zhang. (2018) Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori. Colloids and Surfaces B: Biointerfaces 164, pages 11-19.
Crossref
Crossref
Rongguang Zhang, Chen Wang, Wenbin Cheng, Guangcai Duan, Qingfeng Shi, Shuaiyin Chen & Qingtang Fan. (2018) Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice. Biotechnology Letters 40:3, pages 585-590.
Crossref
Crossref